Therapeutic Monitoring of Tacrolimus
Open Access
- 1 March 1998
- journal article
- other
- Published by SAGE Publications in Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
- Vol. 35 (2) , 167-180
- https://doi.org/10.1177/000456329803500201
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- A Simplified Whole Blood Enzyme-linked Immunosorbent Assay (ProTrac II) for Tacrolimus (FK506) Using Proteolytic Extraction in Place of Organic SolventsTherapeutic Drug Monitoring, 1996
- RELATIONSHIP OF FK506 WHOLE BLOOD CONCENTRATIONS AND EFFICACY AND TOXICITY AFTER LIVER AND KIDNEY TRANSPLANTATIONTransplantation, 1996
- SUGGESTED GUIDELINES FOR THE USE OF TACROLIMUS IN PEDIATRIC LIVER TRANSPLANT PATIENTSTransplantation, 1996
- Pharmacokinetic interpretation of FK 506 levels in blood and in plasma during a European randomised study in primary liver transplant patientsTransplant International, 1994
- Interaction of Tacrolimus (FK506) and Its Metabolites with FKBP and CalcineurinBiochemical and Biophysical Research Communications, 1994
- Comparison of Conformations of Cyclosporin A and Macrolide FK506 Fragments: Localization of Putative Binding Sites with Phosphatase CalcineurinBiochemical and Biophysical Research Communications, 1993
- Detection of the FK506-FKBP-Calcineurin Complex by a Simple Binding AssayBiochemical and Biophysical Research Communications, 1993
- FK 506 interaction with danazolThe Lancet, 1993
- THE IMMUNOSUPPRESSIVE ANTAGONISM OF LOW DOSES OF FK506 AND CYCLOSPORINETransplantation, 1991
- Theophylline Disposition in Patients with Hepatic CirrhosisNew England Journal of Medicine, 1977